| Report ID | 280865 |
| Drug Identification Number | 02486318 |
| Brand name | TRI-JORDYNA 28 |
| Common or Proper name | TRI JORDYNA |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE |
| Strength(s) | 0.035MG 0.18MG 0.035MG 0.215MG 0.035MG 0.25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 3 x 28's |
| ATC code | G03AB |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-03-20 |
| Actual start date | 2026-03-19 |
| Estimated end date | 2026-04-24 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-19 | French | Compare |
| v1 | 2026-03-19 | English | Compare |
Showing 1 to 2 of 2